Early detection of cervical cancer can save lives as the disease is preventable

After being diagnosed with diabetes, many people have numerous questions, especially regarding diet: how much bread to eat, whether to give up sweets. There is also the question of whether diabetic patients can eat fruit, and if so, which ones and which ones should be avoided. This was clarified by Professor Rajesh Hargawat from the Department of Endocrinology at AIIMS Delhi.

He emphasized that most people focus only on the sweetness level when choosing fruits, but the true importance lies not only in sweetness but also in the glycemic load. Glycemic load determines how quickly and to what extent blood sugar will rise after consuming a particular fruit. The quality and quantity of carbohydrates in the product are also taken into account.

Dr. Hargawat explained that two fruits that appear externally similar in sweetness can have different effects: one causes a slow rise in blood sugar, while the other raises it sharply. This difference is what characterizes the glycemic load, so diabetics should pay attention not only to the taste but also to how the fruit will affect the body.

According to Dr. Rajesh Hargawat, fruits with a high glycemic load, such as mango, lychee, and grapes, should be consumed with caution. Excessive consumption of these fruits can lead to a rapid spike in blood sugar levels. However, this does not mean they must be excluded from the diet forever; if the patient's sugar level is stably controlled or the doctor has recommended caution, these fruits should not become part of the daily menu.

The specialist noted that fruits with a low glycemic load are preferable for diabetic patients. Examples of such fruits include apples and guavas. The advantage of these fruits lies not only in their low sugar content but also in their high fiber content.

Furthermore, Dr. Rajesh advised diabetics to follow certain rules when consuming fruit. It is important not to overeat, and it is better to combine fruits with milk or yogurt.

The World Health Organization (WHO) called on Tuesday for comprehensive support to counter the Ebola outbreak raging in the Democratic Republic of Congo (DRC), which continues to outpace response efforts.

WHO representative Tarik Jasarevic stated in Geneva that the outbreak, unfortunately, is exceeding the capacity of the current response. He emphasized the need for additional financial aid and other resources to expand all areas of work, including treatment facilities, field investigation teams, safe burial groups, and public outreach.

According to the WHO, 3,802 confirmed cases of Ebola have been registered in the DRC, resulting in 1,707 deaths. Furthermore, 727 patients have recovered, and 275 suspected cases are under investigation. Currently, 17,000 contacts of infected individuals are being monitored, with over 80% undergoing daily checks.

Although cases have been recorded in five provinces, nearly 90% are concentrated in the northeastern province of Ituri, with the remainder focused in the neighboring North Kivu province. Jasarevic noted that the response must be focused on the areas of current virus spread and potential future risk zones.

Various trials of potential therapies, vaccines, and antiviral drugs are currently underway following exposure. Wasse Moorti, WHO's head of research and development, reported that preliminary results look promising. Moorti added that new data is emerging regarding whether the vaccine Ervebo, which acts against the Zaire ebolavirus, provides cross-protection against the Bundibugyo virus in animals.

The WHO Advisory Group on Vaccines reviewed the relevant data on Friday and plans to publish recommendations later this week. Among the two leading candidate vaccines are one based on the ChAdOx1 platform, developed by Oxford University and the Indian Serological Institute, and another created by the American pharmaceutical company Moderna using mRNA technology.

Depending on the results obtained, developers will determine the optimal dosage level for transitioning to full-scale Phase III clinical trials in humans. In the Ituri province, two potential treatments are being tested among confirmed Ebola patients: the monoclonal antibody MBP134 and the antiviral drug remdesivir, both alone and in combination. Concurrently, a study is being conducted on the antiviral drug obeldesivir for people who have been exposed to confirmed Bundibugyo cases.

Moorti reported that more than 25 high-risk individuals in Ituri have been enrolled to assess whether this oral medication, taken for 10 days, can prevent the development of the disease.

After twins in Anantapuram died because their seriously ill mother could not breastfeed them, this tragedy deeply affected Dr. G. Gemalath and raised a vital question: what if every child had access to mother's milk?

This question led to the creation of the Ananta Breast Milk Bank in 2025. Today, healthy mothers donate their surplus breast milk so that premature, orphaned, and seriously ill newborns never experience a lack of necessary nutrition.

Every donor undergoes thorough testing for HIV, hepatitis B, and other infections. The milk is pasteurized, retested, safely stored, and provided absolutely free of charge to the smallest and most vulnerable infants.

Dr. G. Gemalath's efforts were not limited to the hospital. When new mothers could not reach the facility, Dr. G. Gemalath organized collections of donated breast milk from villages, sometimes using her own transport.

The public response was exceptional: over 5000 mothers donated, providing more than 600 liters of breast milk after feeding their own children, and expecting nothing in return.

Among them was Lavanya, who was often asked if she received payment for her donation. She replied that 'good deeds should be encouraged, not discouraged. Mother's milk is one of the purest things in this world.'

The breast milk bank has counseled over 40,000 mothers and helped raise over 4000 newborns weighing only 800 grams. Every drop gave another chance at survival. Although these women rarely meet the babies they save, every bottle they donate carries hope, love, and life. In Anantapuram, thousands of newborns have gained more than just nutrition—they have found countless mothers.